I believe that Dr. Greenwood is continuing to use the CCS terminology, and I can’t see any substantial difference between the NovoSkin CCS and the CCS mentioned within Dr. Greenwood’s Skin Tissue Engineering venture. (See Dr. Greenwood’s linkdin profile)
I am certain that what has happened is that PolyNovo is concentrating on its core business and is leaving bioreactors etc. to Dr. Greenwood. I expect that there will be a significant level of coordination and cooperation between PolyNovo and Skin T.E. as I believe that Dr. Greenwood will continue to use a NovoSorb scaffold.
In short, while there may have been a rejiggering of the relationship between Dr. Greenwood and PolyNovo with respect to the CCS, I don’t think the CCS itself has changed much, although it could be subject to continuous improvement.
- Forums
- ASX - By Stock
- PNV
- What Dr John had to say
What Dr John had to say, page-6
Featured News
Add PNV (ASX) to my watchlist
|
|||||
Last
$2.61 |
Change
0.030(1.16%) |
Mkt cap ! $1.801B |
Open | High | Low | Value | Volume |
$2.66 | $2.69 | $2.59 | $2.721M | 1.035M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 4039 | $2.60 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.61 | 33 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 4039 | 2.600 |
1 | 28750 | 2.590 |
7 | 20302 | 2.580 |
2 | 10970 | 2.570 |
2 | 3540 | 2.560 |
Price($) | Vol. | No. |
---|---|---|
2.610 | 33 | 1 |
2.620 | 4094 | 2 |
2.630 | 15609 | 4 |
2.640 | 12970 | 3 |
2.650 | 18060 | 4 |
Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
Featured News
PNV (ASX) Chart |